Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

1.

Antiangiogenic tetrathiomolybdate protects against Her2/neu-induced breast carcinoma by hypoplastic remodeling of the mammary gland.

Pan Q, Rosenthal DT, Bao L, Kleer CG, Merajver SD.

Clin Cancer Res. 2009 Dec 1;15(23):7441-6. doi: 10.1158/1078-0432.CCR-09-1361. Epub 2009 Nov 24.

PMID:
19934283
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Intraductally administered pegylated liposomal doxorubicin reduces mammary stem cell function in the mammary gland but in the long term, induces malignant tumors.

Chun YS, Yoshida T, Mori T, Huso DL, Zhang Z, Stearns V, Perkins B, Jones RJ, Sukumar S.

Breast Cancer Res Treat. 2012 Aug;135(1):201-8. doi: 10.1007/s10549-012-2138-x. Epub 2012 Jul 1.

PMID:
22752247
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.

Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.

Cancer Res. 2006 May 1;66(9):4672-80.

PMID:
16651418
[PubMed - indexed for MEDLINE]
Free Article
4.

Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice.

Alli PM, Pinn ML, Jaffee EM, McFadden JM, Kuhajda FP.

Oncogene. 2005 Jan 6;24(1):39-46.

PMID:
15489885
[PubMed - indexed for MEDLINE]
5.

Genetic modulation of neu proto-oncogene-induced mammary tumorigenesis.

Rowse GJ, Ritland SR, Gendler SJ.

Cancer Res. 1998 Jun 15;58(12):2675-9.

PMID:
9635596
[PubMed - indexed for MEDLINE]
Free Article
6.

Prime-boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu+ metastatic breast cancer in mice.

Wang X, Wang JP, Rao XM, Price JE, Zhou HS, Lachman LB.

Breast Cancer Res. 2005;7(5):R580-8. Epub 2005 May 23.

PMID:
16168101
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.

Anisimov VN, Khavinson VK, Provinciali M, Alimova IN, Baturin DA, Popovich IG, Zabezhinski MA, Imyanitov EN, Mancini R, Franceschi C.

Int J Cancer. 2002 Sep 1;101(1):7-10.

PMID:
12209581
[PubMed - indexed for MEDLINE]
8.

Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.

Pan Q, Kleer CG, van Golen KL, Irani J, Bottema KM, Bias C, De Carvalho M, Mesri EA, Robins DM, Dick RD, Brewer GJ, Merajver SD.

Cancer Res. 2002 Sep 1;62(17):4854-9.

PMID:
12208730
[PubMed - indexed for MEDLINE]
Free Article
9.

Changes associated with delay of mammary cancer by retinoid analogues in transgenic mice bearing c-neu oncogene.

Rao GN, Ney E, Herbert RA.

Breast Cancer Res Treat. 1999 Dec;58(3):241-54.

PMID:
10718486
[PubMed - indexed for MEDLINE]
10.

Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination.

Pupa SM, Iezzi M, Di Carlo E, Invernizzi A, Cavallo F, Meazza R, Comes A, Ferrini S, Musiani P, Ménard S.

Cancer Res. 2005 Feb 1;65(3):1071-8.

PMID:
15705909
[PubMed - indexed for MEDLINE]
Free Article
11.

Stromal-epithelial interactions modulate cross-talk between prolactin receptor and HER2/Neu in breast cancer.

Xu C, Langenheim JF, Chen WY.

Breast Cancer Res Treat. 2012 Jul;134(1):157-69. doi: 10.1007/s10549-012-1954-3. Epub 2012 Jan 22.

PMID:
22270933
[PubMed - indexed for MEDLINE]
12.

Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.

Jacquemart IC, Springs AE, Chen WY.

Int J Oncol. 2009 Feb;34(2):517-28.

PMID:
19148488
[PubMed - indexed for MEDLINE]
13.

Therapeutic activity of sunitinib for Her2/neu induced mammary cancer in FVB mice.

Abe F, Younos I, Westphal S, Samson H, Scholar E, Dafferner A, Hoke TA, Talmadge JE.

Int Immunopharmacol. 2010 Jan;10(1):140-5. doi: 10.1016/j.intimp.2009.09.023. Epub 2009 Oct 12.

PMID:
19833232
[PubMed - indexed for MEDLINE]
14.

Effect of the silybin-phosphatidylcholine complex (IdB 1016) on the development of mammary tumors in HER-2/neu transgenic mice.

Provinciali M, Papalini F, Orlando F, Pierpaoli S, Donnini A, Morazzoni P, Riva A, Smorlesi A.

Cancer Res. 2007 Mar 1;67(5):2022-9.

PMID:
17332330
[PubMed - indexed for MEDLINE]
Free Article
15.

Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.

Liu JC, Deng T, Lehal RS, Kim J, Zacksenhaus E.

Cancer Res. 2007 Sep 15;67(18):8671-81.

PMID:
17875707
[PubMed - indexed for MEDLINE]
Free Article
16.

Influence of antibiotic treatment on breast carcinoma development in proto-neu transgenic mice.

Rossini A, Rumio C, Sfondrini L, Tagliabue E, Morelli D, Miceli R, Mariani L, Palazzo M, Ménard S, Balsari A.

Cancer Res. 2006 Jun 15;66(12):6219-24.

PMID:
16778196
[PubMed - indexed for MEDLINE]
Free Article
17.

Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo.

Anisimov VN, Egormin PA, Piskunova TS, Popovich IG, Tyndyk ML, Yurova MN, Zabezhinski MA, Anikin IV, Karkach AS, Romanyukha AA.

Cell Cycle. 2010 Jan 1;9(1):188-97. Epub 2010 Jan 22.

PMID:
20016287
[PubMed - indexed for MEDLINE]
Free Article
18.

In vivo effect of alpha-bisabolol, a nontoxic sesquiterpene alcohol, on the induction of spontaneous mammary tumors in HER-2/neu transgenic mice.

Costarelli L, Malavolta M, Giacconi R, Cipriano C, Gasparini N, Tesei S, Pierpaoli S, Orlando F, Suzuki H, Perbellini L, Piacenza F, Emanuelli M, Mocchegiani E.

Oncol Res. 2010;18(9):409-18.

PMID:
20524399
[PubMed - indexed for MEDLINE]
19.

Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12.

Nanni P, Nicoletti G, De Giovanni C, Landuzzi L, Di Carlo E, Iezzi M, Ricci C, Astolfi A, Croci S, Marangoni F, Musiani P, Forni G, Lollini PL.

Int J Cancer. 2003 Jun 20;105(3):384-9.

PMID:
12704673
[PubMed - indexed for MEDLINE]
20.

Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma.

Pan Q, Bao LW, Kleer CG, Brewer GJ, Merajver SD.

Mol Cancer Ther. 2003 Jul;2(7):617-22.

PMID:
12883034
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk